Literature DB >> 12608313

[Amblyopia in myopia in patients with strabismus and without strabismus].

Maciej Gawecki1, Danuta Fabiszewska-Górny.   

Abstract

PURPOSE: To determine factors, which have influence on presence of strabismus among myopic patients with amblyopia.
MATERIAL AND METHODS: Material covers 21 myopic patients with amblyopia, aged 6-15. All children presented have a different amount of anisometropia, 12 of them had strabismus. Authors, compared the group of patients with amblyopia and strabismus (12) with the group of patients with pure anisometropic amblyopia (9), according to the following criteria: age of presentation, best corrected visual acuity, mean refraction error of amblyopic eye, mean amount of anisometropia, percentage of patients with central fixation and binocular vision.
RESULTS: Patients with strabismus presented oneself earlier than patients without squint. Best corrected visual acuity was better in patients without strabismus. Refraction error in both groups has similar value. Amount of anisometropia was slightly smaller in the group with squint. Central fixation and binocular vision were better preserved among patients without strabismus. Authors didn't find the following correlations too: correlation between amount of anisometropia and amount of amblyopia in both groups, correlation between amount of anisometropia and the amount of the deviation of squinting eye, correlation between depth of amblyopia and the amount of deviation of the squinting eye.
CONCLUSION: It seems, that primary factor leading to presence of strabismus among patients with anisometropic myopia, is motor dysfunction of extraocular muscles.

Entities:  

Mesh:

Year:  2002        PMID: 12608313

Source DB:  PubMed          Journal:  Klin Oczna        ISSN: 0023-2157


  1 in total

1.  Evaluation of 'vision screening' program for three to six-year-old children in the Republic of Iran.

Authors:  Rajiv Khandekar; Noa Parast; Ashraf Arabi
Journal:  Indian J Ophthalmol       Date:  2009 Nov-Dec       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.